A new study raises questions about how to allocate the enormous resources that are being dedicated to certain drugs for rare diseases.

Work by Charles Rice and colleagues paved the way for the rapid development of antiviral drugs that can now cure approximately 95% of Hepatitis C patients.

Cancer research is at an “inflection point” where scientists must adapt to new ways of sharing data and putting patients at the center of care, said former Vice President Joseph R. Biden, Jr. at the 2018 AAAS Annual Meeting.

In his years as a practicing physician, researcher, and hospital administrator, Brad Spellberg has devoted extensive time to communicating about antibiotic resistance.

Deaths by accidental overdose of opioids are rising sharply, due to a new source of more potent, readily available synthetic opioid drugs. Opioid overdoses have already caused the country’s overall death rate to increase in 2015, the first time since 1993, when the country was coming to grips with AIDS. And, “the worst is yet to come,” a drug court judge said during a panel at the 2017 AAAS Science & Technology Policy Forum, which was held March 27-28 in Washington.